A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

Psychopharmacology

Volumn 122, Issue 4, 1995, Pages 386-389

  Baker, D G ^a   Diamond, B I ^a   Gillette, G ^b   Hamner, M ^c   Katzelnick, D ^d   Keller, T ^a   Mellman, T A ^e   Pontius, E ^a   Rosenthal, M ^f   Tucker, P ^g   vander Kolk, B A ^h   Katz, R ⁱ  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d Dean Foundation for Health   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Ciba Geigy Corportation ^*  (United States)

^g UNIVERSITY OF OKLAHOMA   (United States)

^h NONE   (United States)

ⁱ NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Brofaromine; MAOI; Psychopharmacology; PTSD

Indexed keywords

BROFAROMINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PIPERIDINES; STRESS DISORDERS, POST-TRAUMATIC;

EID: 9044249718     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/BF02246271     Document Type: Article

References (15)

1. A clinician rating scale for assessing current and lifetime PTSD: the CAPS 1
2. Core symptoms of posttraumatic stress disorder unimproved by alprozolam treatment
3. Traumatic events and posttraumatic stress disorder in an urban population of young adults
4. Treatment of posttraumatic stress disorder with amitriptyline and placebo
5. Posttraumatic stress disorder in the community: an epidemiological study
6. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder
7. Posttraumatic stress disorder in a general population: finding of the epidemiological catchment area survey
8. Impact of event scale: a measure of subjective stress
9. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic
10. Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine
11. Brofaromine-a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacologic and clinical findings
12. A new depression scale designed to be responsive to change
13. A controlled trial of desipramine in 18 men with posttraumatic stress disorder
14. A controlled trial of phenelzine in posttraumatic stress disorder
15. Fluoxetine treatment in post traumatic stress disorder